Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Connors

Showing results (731-740 of 808) with videos related to

Pageof 81
Sort By:
Nature|March 4, 2011
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancersChristian Steidl, Sohrab P Shah, Bruce W Woolcock, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2008
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysGeorg Lenz, George W Wright, N C Tolga Emre, et al.
Leukemia|July 13, 2007
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphomaJ Iqbal, T C Greiner, K Patel, et al.
Blood Advances|June 27, 2020
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaChristopher K Rushton, Sarah E Arthur, Miguel Alcaide, et al.
Cancer Discovery|February 5, 2014
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphismsYibin Yang, Roland Schmitz, Joseph Mitala, et al.
Journal of the American College of Cardiology|January 17, 2024
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art ReviewAntoine Bejjani, Candrika D Khairani, Ali Assi, et al.
The New England Journal of Medicine|December 12, 2017
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's LymphomaJoseph M Connors, Wojciech Jurczak, David J Straus, et al.
Blood|September 17, 2013
Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphomaAlyssa Bouska, Timothy W McKeithan, Karen E Deffenbacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell LymphomaDaisuke Ennishi, Aixiang Jiang, Merrill Boyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Active idiotypic vaccination versus control immunotherapy for follicular lymphomaRonald Levy, Kristen N Ganjoo, John P Leonard, et al.
Pageof 81

Showing results (731-740 of 808) with videos related to

Sort By:
Pageof 81
Nature|March 4, 2011
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancersChristian Steidl, Sohrab P Shah, Bruce W Woolcock, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2008
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysGeorg Lenz, George W Wright, N C Tolga Emre, et al.
Leukemia|July 13, 2007
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphomaJ Iqbal, T C Greiner, K Patel, et al.
Blood Advances|June 27, 2020
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaChristopher K Rushton, Sarah E Arthur, Miguel Alcaide, et al.
Cancer Discovery|February 5, 2014
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphismsYibin Yang, Roland Schmitz, Joseph Mitala, et al.
Journal of the American College of Cardiology|January 17, 2024
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art ReviewAntoine Bejjani, Candrika D Khairani, Ali Assi, et al.
The New England Journal of Medicine|December 12, 2017
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's LymphomaJoseph M Connors, Wojciech Jurczak, David J Straus, et al.
Blood|September 17, 2013
Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphomaAlyssa Bouska, Timothy W McKeithan, Karen E Deffenbacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell LymphomaDaisuke Ennishi, Aixiang Jiang, Merrill Boyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Active idiotypic vaccination versus control immunotherapy for follicular lymphomaRonald Levy, Kristen N Ganjoo, John P Leonard, et al.
Pageof 81